rs10511793
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_001031689.3(PLAA):c.869+1202A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.209 in 152,120 control chromosomes in the GnomAD database, including 4,020 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.21 ( 4020 hom., cov: 32)
Consequence
PLAA
NM_001031689.3 intron
NM_001031689.3 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 0.331
Publications
3 publications found
Genes affected
PLAA (HGNC:9043): (phospholipase A2 activating protein) Predicted to enable ubiquitin binding activity. Involved in cellular response to lipopolysaccharide; macroautophagy; and positive regulation of phospholipase A2 activity. Located in cytoplasm; extracellular exosome; and nucleus. [provided by Alliance of Genome Resources, Apr 2022]
PLAA Gene-Disease associations (from GenCC):
- neurodevelopmental disorder with progressive microcephaly, spasticity, and brain anomaliesInheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.97).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.342 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.209 AC: 31803AN: 152002Hom.: 4004 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
31803
AN:
152002
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.209 AC: 31862AN: 152120Hom.: 4020 Cov.: 32 AF XY: 0.207 AC XY: 15381AN XY: 74368 show subpopulations
GnomAD4 genome
AF:
AC:
31862
AN:
152120
Hom.:
Cov.:
32
AF XY:
AC XY:
15381
AN XY:
74368
show subpopulations
African (AFR)
AF:
AC:
14383
AN:
41474
American (AMR)
AF:
AC:
2332
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
AC:
796
AN:
3466
East Asian (EAS)
AF:
AC:
180
AN:
5176
South Asian (SAS)
AF:
AC:
1160
AN:
4820
European-Finnish (FIN)
AF:
AC:
1286
AN:
10594
Middle Eastern (MID)
AF:
AC:
88
AN:
294
European-Non Finnish (NFE)
AF:
AC:
10981
AN:
67992
Other (OTH)
AF:
AC:
471
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1240
2480
3721
4961
6201
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
565
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.